TELMIWAL-M
| Brand | TELMIWAL-M |
|---|---|
| Composition | Telmisartan 40mg + Metoprolol Succinate 23.75mg eq to Metoprolol Tartrate 25mg |
| Packing | 10x10 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about TELMIWAL-MIndication
Management of essential hypertension (high blood pressure) in patients requiring combination therapy.
Mechanism of action
Telmisartan blocks angiotensin II type-1 (AT1) receptors, reducing blood vessel narrowing. Metoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing heart rate and cardiac output.
For pharmaceutical trade information, not a patient-specific prescription. Use the current approved product insert and the prescribing clinician's directions.
TELMIWAL-M for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
CILATOP TRIO 25
BISINTRA-TM 2.5/40 TABS
TELMIWAL-40
CILATOP-TM